Teva launches anti-cancer treatment; Issachar Weiss, a volunteer paramedic for Magen David Adom in the Tel Aviv area, sets new record; Israeli startup Diagnostic Robotics develops AI Emergency Room triage robot that assesses urgency of each patient; and more!

By Michael Ordman


Teva launches anti-cancer treatment

Israel’s Teva is launching Truxima, a biosimilar for Rituxan – Roche’s oncology treatment. It is initially targeted at non-Hodgkin’s Lymphoma patients but also could treat rheumatoid arthritis and other conditions.

Volunteer paramedic delivers 3 babies in 48 hours

Israel’s Issachar Weiss is a volunteer paramedic for Magen David Adom in the Tel Aviv area. He delivered one baby at 4:30am Sunday in Givatayim, another at 5am Monday in Bnei Brak and a third at 5pm Monday in Hatikvah Tel Aviv. It may be a new record.

The robot will see you now

Israeli startup Diagnostic Robotics has developed an Artificial Intelligent Emergency Room triage robot that assesses the urgency of each patient to determine their priority in seeing a human doctor. The robot also provides the doctor with a preliminary diagnosis and recommendations.

Good results in sepsis treatment trial

As reported previously (see here) Israel’s Enlivex Therapeutics has developed Allocetra which rebalances the immune system. Allocetra was given to six patients suffering from severe sepsis at Hadassah hospital in Jerusalem. All survived.

Amazing medical innovations

Great video by Naftali Hananya about Israeli medical innovations previously reported in this newsletter. It highlights nano eye drops to restore vision (see here); Savicell’s lung cancer test (see here); the multiple myeloma treatment XPOVIO (see here); and Relivion’s migraine headset (see here);

Early diagnosis of autism

Professor Ilan Dinstein of Israel’s Ben Gurion University has developed a method of detecting children with autism spectrum disorder (ASD) from the early age of 18 months. He tracks eye-movements of children watching films. ASD children have significantly more idiosyncratic gaze patterns.

Another discovery about memory

Researchers from Ben-Gurion University working with Spanish scientists have discovered that single-cell organisms such as amoebas are capable of developing memory capabilities. The breakthrough could help treat patients suffering from neurodegenerative diseases such as Alzheimer’s.

Seven joint UK-Israel medical projects

The British-Israel research organization BIRAX is granting funds of £2.8 million to seven, new, three-year bilateral scientific research projects in the field of ageing. These focus on vascular, brain and eye diseases, plus diabetes and involve precision medicine and Artificial Intelligence.

Sheba’s Innovation Center

Israel’s Sheba Medical Center has launched its ARC Innovation Center, with world-class medics plus top technology experts developing new approaches for treatment and rehabilitation. It is the first hospital in the world to provide a virtual reality rehab facility.


Israelis Under Attack - Donate